NEOS Investment Management LLC lifted its holdings in shares of Humana Inc. (NYSE:HUM – Free Report) by 10.7% during the second quarter, Holdings Channel reports. The fund owned 19,136 shares of the insurance provider’s stock after purchasing an additional 1,842 shares during the quarter. NEOS Investment Management LLC’s holdings in Humana were worth $7,601,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of Humana in the 2nd quarter valued at approximately $4,138,160,000. Capital International Investors raised its holdings in Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after acquiring an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC boosted its stake in Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock valued at $948,614,000 after acquiring an additional 1,398,774 shares during the last quarter. State Street Corp grew its holdings in Humana by 1.8% during the 4th quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after acquiring an additional 97,211 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Humana by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 3,184,569 shares of the insurance provider’s stock worth $812,540,000 after purchasing an additional 23,732 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms recently commented on HUM. Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a research note on Wednesday, May 20th. Guggenheim lifted their target price on Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Needham & Company LLC initiated coverage on Humana in a research report on Wednesday, May 20th. They set a “buy” rating on the stock. Cantor Fitzgerald restated a “neutral” rating on shares of Humana in a research note on Friday. Finally, Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price objective for the company in a report on Thursday, July 30th. Fourteen analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $403.91.
Humana Stock Performance
Shares of NYSE HUM opened at $400.70 on Friday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm’s 50-day moving average price is $388.44 and its two-hundred day moving average price is $296.00. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The stock has a market capitalization of $48.12 billion, a P/E ratio of 37.91, a P/E/G ratio of 2.63 and a beta of 0.74.
Humana (NYSE:HUM – Get Free Report) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business’s revenue was up 26.2% compared to the same quarter last year. During the same period in the prior year, the company earned $6.27 earnings per share. As a group, sell-side analysts forecast that Humana Inc. will post 9 earnings per share for the current year.
Humana Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana’s dividend payout ratio (DPR) is currently 33.49%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Stories
- Five stocks we like better than Humana
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
